insider24.ch
Back to the feed

Shareholding disclosure

Amgen Inc

inKuros Biosciences AG

Declared position

3.5%

Threshold

Crossed upwards

Timeline

Published

05.02.2015

Transaction

30.01.2015

Voting rights breakdown

Voting rights acquired3.5%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAF2300057

Beneficial owner

Amgen Inc

Declared address

Amgen Inc., 19808 Wilmington

Expiry of the conversion rights under the convertible loan notes. Warrants are directly held by Amgen Investments Ltd.,Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda, which is owned 100% by Amgen Manufacturing Ltd.,Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda. Amgen Manufacturing Ltd. is owned 100% by Amgen Technology Ltd., Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda, which is owned 10% by Amgen International LLC, 2711 Centerville Road, Suite 400 Wilmington, DE 19808, USA, and 90% by Amgen Inc., 2711 Centerville Road, Wilmington, DE 19808, USA, a public company listed on the NASDAQ. Amgen Inc. owns 100% of Amgen International LLC.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open